AIM 27 March 2019 NOTICE 27/03/2019 - 7:00am NOTICE OF CANCELLATION OF ADMISSION TO TRADING ON AIM - XLON At the request of the company the following securities have been cancelled from trading...
Realm Therapeutics Announces Cancellation of AIM Listing PR Newswire MALVERN, Pa., March 26, 2019 MALVERN, Pa., March 26, 2019 /PRNewswire/ -- Realm Therapeutics plc (NASDAQ: RLM / AIM: RLM), a...
Realm Therapeutics PLC 26 March 2019 Realm Therapeutics plc ("Realm", "Realm Therapeutics" or the "Company") Cancellation of AIM Listing MALVERN, PA, March 26, 2019...
Realm Therapeutics PLC 25 March 2019 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in...
Realm Therapeutics PLC 25 March 2019 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange...
Nplus1 Singer Capital Markets Ltd 20 March 2019 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...
Nplus1 Singer Capital Markets Ltd 18 March 2019 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...
Nplus1 Singer Capital Markets Ltd 18 March 2019 FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY...
Realm Therapeutics Announces Result of General Meeting All Resolutions Passed Reminder: Process to Convert Ordinary Shares into ADSs PR Newswire MALVERN, Pa., March 15, 2019 MALVERN, Pa., March...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |